Vericel (VCEL) Non-Current Assets (2010 - 2026)

Vericel's (VCEL) quarterly Non-Current Assets came in at $241.6 million in Q1 2026, up 6.44% year-on-year from $226.9 million in Q1 2025, and little changed quarter-over-quarter from $240.5 million in Q4 2025.

Vericel (VCEL) Non-Current Assets (2010 - 2026) Analysis & Trends

Vericel has disclosed Non-Current Assets across 17 years of filings, most recently posting $241.6 million for Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $241.6 million, up 6.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $944.4 million (up 14.31% YoY), and the FY2025 annual result was $240.5 million, up 9.36% from the prior year.
  • Non-Current Assets came in at $241.6 million for Q1 2026 at Vericel, roughly flat from $240.5 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $241.6 million in Q1 2026 to a low of $81.6 million in Q3 2022.
  • The 5-year median for Non-Current Assets is $166.9 million (2024), against an average of $163.5 million.
  • Across the five-year window, Non-Current Assets fell 0.97% in 2023 and soared 90.68% in 2024, its largest moves.
  • Vericel's Non-Current Assets stood at $86.1 million in 2022, then soared by 71.85% to $148.0 million in 2023, then jumped by 48.59% to $219.9 million in 2024, then rose by 9.36% to $240.5 million in 2025, then rose by 0.43% to $241.6 million in 2026.
  • The last three Non-Current Assets figures came in at $241.6 million (Q1 2026), $240.5 million (Q4 2025), and $231.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn 241.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 241.56 Mn
Dec 31, 2025 240.53 Mn
Sep 30, 2025 231.31 Mn
Jun 30, 2025 231.03 Mn
Mar 31, 2025 226.95 Mn
Dec 31, 2024 219.95 Mn
Sep 30, 2024 199.89 Mn
Jun 30, 2024 179.45 Mn
Mar 31, 2024 166.94 Mn
Dec 31, 2023 148.03 Mn
Sep 30, 2023 131.91 Mn
Jun 30, 2023 127.84 Mn
Mar 31, 2023 87.55 Mn
Dec 31, 2022 86.14 Mn
Sep 30, 2022 81.64 Mn
Jun 30, 2022 89.72 Mn
Mar 31, 2022 88.41 Mn
Dec 31, 2021 85.24 Mn
Sep 30, 2021 79.20 Mn
Jun 30, 2021 83.43 Mn